Article Details

Pfizer's investigational meningococcal vaccine shows promise in phase 3 trial - PMLiVE

Retrieved on: 2022-09-16 11:37:13

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's investigational meningococcal vaccine shows promise in phase 3 trial - PMLiVE. View article details on hiswai:

Excerpt

If approved, Pfizer's MenABCWY could help simplify the meningococcal vaccination schedule by reducing the total number of doses needed for individuals ...

Article found on: www.pmlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up